|
1
|
Brown JS, Lowe D, Kalavrezos N, D'Souza J,
Magennis P and Woolgar J: Patterns of invasion and routes of tumor
entry into the mandible by oral squamous cell carcinoma. Head Neck.
24:370–383. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaw RJ, Brown JS, Woolgar JA, Lowe D,
Rogers SN and Vaughan ED: The influence of the pattern of
mandibular invasion on recurrence and survival in oral squamous
cell carcinoma. Head Neck. 26:861–869. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takada H, Ibaragi S, Eguchi T, Okui T,
Obata K, Masui M, Morisawa A, Takabatake K, Kawai H, Yoshioka N, et
al: Semaphorin 4D promotes bone invasion in head and neck squamous
cell carcinoma. Int J Oncol. 51:625–632. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spence JA, Suttle NF, Wenham G, El-Gallad
T and Bremner I: A sequential study of the skeletal abnormalities
which develop in rats given a small dietary supplement of ammonium
tetrathiomolybdate. J Comp Pathol. 90:139–153. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith BJ, King JB, Lucas EA, Akhter MP,
Arjmandi BH and Stoecker BJ: Skeletal unloading and dietary copper
depletion are detrimental to bone quality of mature rats. J Nutr.
132:190–196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roberts EA and Schilsky ML; American
Association for Study of Liver Diseases (AASLD): Diagnosis and
treatment of Wilson disease: An update. Hepatology. 47:2089–2111.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan N, Willis A, Kornhauser N, Ward MM,
Lee SB, Nackos E, Seo BR, Chuang E, Cigler T, Moore A, et al:
Influencing the tumor microenvironment: A phase II study of copper
depletion using tetrathiomolybdate in patients with breast cancer
at high risk for recurrence and in preclinical models of lung
metastases. Clin Cancer Res. 23:666–676. 2017. View Article : Google Scholar
|
|
8
|
Hassouneh B, Islam M, Nagel T, Pan Q,
Merajver SD and Teknos TN: Tetrathiomolybdate promotes tumor
necrosis and prevents distant metastases by suppressing
angiogenesis in head and neck cancer. Mol Cancer Ther. 6:1039–1045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhuvanasundar R, John A, Sulochana KN,
Coral K, Deepa PR and Umashankar V: A molecular model of human
Lysyl Oxidase (LOX) with optimal copper orientation in the
catalytic cavity for induced fit docking studies with potential
modulators. Bioinformation. 10:406–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rucker RB, Kosonen T, Clegg MS, Mitchell
AE, Rucker BR, Uriu-Hare JY and Keen CL: Copper, lysyl oxidase, and
extracellular matrix protein cross-linking. Am J Clin Nutr.
67(Suppl): S996–S1002. 1998. View Article : Google Scholar
|
|
11
|
Tsukasaki M, Hamada K, Okamoto K,
Nagashima K, Terashima A, Komatsu N, Win SJ, Okamura T, Nitta T,
Yasuda H, et al: LOX fails to substitute for RANKL in
osteoclastogenesis. J Bone Miner Res. 32:434–439. 2017. View Article : Google Scholar
|
|
12
|
Cox TR, Rumney RMH, Schoof EM, Perryman L,
Høye AM, Agrawal A, Bird D, Latif NA, Forrest H, Evans HR, et al:
The hypoxic cancer secretome induces pre-metastatic bone lesions
through lysyl oxidase. Nature. 522:106–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reynaud C, Ferreras L, Di Mauro P, Kan C,
Croset M, Bonnelye E, Pez F, Thomas C, Aimond G, Karnoub AE, et al:
Lysyl oxidase is a strong determinant of tumor cell colonization in
bone. Cancer Res. 77:268–278. 2017. View Article : Google Scholar
|
|
14
|
Teramachi J, Nagata Y, Mohammad K, Inagaki
Y, Ohata Y, Guise T, Michou L, Brown JP, Windle JJ, Kurihara N, et
al: Measles virus nucleocapsid protein increases osteoblast
differentiation in Paget's disease. J Clin Invest. 126:1012–1022.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shah KM, Stern MM, Stern AR, Pathak JL,
Bravenboer N and Bakker AD: Osteocyte isolation and culture
methods. Bonekey Rep. 5:8382016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park SJ, Kim MJ, Kim YK, Kim SM, Park JY
and Myoung H: Combined cetuximab and genistein treatment shows
additive anti-cancer effect on oral squamous cell carcinoma. Cancer
Lett. 292:54–63. 2010. View Article : Google Scholar
|
|
17
|
Chisholm CL, Wang H, Wong AH,
Vazquez-Ortiz G, Chen W, Xu X and Deng CX: Ammonium
tetrathiomolybdate treatment targets the copper transporter ATP7A
and enhances sensitivity of breast cancer to cisplatin. Oncotarget.
7:84439–84452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krebs CJ and Krawetz SA: Lysyl oxidase
copper-talon complex: A model. Biochim Biophys Acta. 1202:7–12.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shih YH, Chang KW, Chen MY, Yu CC, Lin DJ,
Hsia SM, Huang HL and Shieh TM: Lysyl oxidase and enhancement of
cell proliferation and angiogenesis in oral squamous cell
carcinoma. Head Neck. 35:250–256. 2013. View Article : Google Scholar
|
|
20
|
Cox TR, Gartland A and Erler JT: Lysyl
oxidase, a targetable secreted molecule involved in cancer
metastasis. Cancer Res. 76:188–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gartland A, Erler JT and Cox TR: The role
of lysyl oxidase, the extracellular matrix and the pre-metastatic
niche in bone metastasis. J Bone Oncol. 5:100–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim KK, Han A, Yano N, Ribeiro JR, Lokich
E, Singh RK and Moore RG: Tetrathiomolybdate mediates
cisplatin-induced p38 signaling and EGFR degradation and enhances
response to cisplatin therapy in gynecologic cancers. Sci Rep.
5:159112015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang H, Leung L, Saturno G, Viros A, Smith
D, Di Leva G, Morrison E, Niculescu-Duvaz D, Lopes F, Johnson L, et
al: Lysyl oxidase drives tumour progression by trapping EGF
receptors at the cell surface. Nat Commun. 8:149092017. View Article : Google Scholar : PubMed/NCBI
|
